Alice Chen

Dr. Alice Chen has over 25 years of experience in the biotech and pharmaceutical industry. She brings extensive experience in technology innovation, biologics and small molecule drug discovery, MOA research, as well as translational science expertise to Baylink. She held scientific and leadership roles at Novartis, NGM Biopharmaceuticals, 23andMe, and Asieris Pharmaceuticals where she contributed to the development of numerous drugs targeting oncology, metabolic disease, and autoimmune diseases. Prior to joining Baylink, she was SVP of Biology and Head of Translational Research at Asieris Pharmaceuticals. She received her Ph.D. in Neurosciences from Stanford University, and BS in Biology from Caltech.